ikb alpha Latest Buying Tips,Rabbit Polyclonal IKB alpha antibody

IκBα, also known as NF-kappa-B inhibitor alpha or IKBA, is a crucial protein that plays a pivotal role in regulating the activity of the NF-κB transcription factor. This protein family, including inhibitory IkB proteins (alpha, beta, epsilon), acts as a gatekeeper, preventing NF-κB from entering the cell's nucleus and initiating gene transcription. Understanding IκBα is fundamental to comprehending cellular responses to various stimuli, including inflammation, immunity, and cell survival.

The Molecular Mechanism of IκBα Action

At its core, IκBα functions by binding to NF-κB dimers in the cytoplasm. This interaction inhibits the activity of dimeric NF-kappa-B/REL complexes by effectively masking their nuclear localization signals. This sequestration keeps the NF-κB complex inactive and prevents it from translocating to the nucleus where it would normally bind to DNA and activate gene expression. This mechanism is a critical control point in cellular signaling.

The NFKBIA gene encodes the IκBα protein, which is approximately 40 kDa in size. This protein is a key member of the IkB family of proteins, which are characterized by the presence of multiple ankyrin repeat domains. These domains are essential for the protein-protein interactions that mediate the binding to NF-κB.

Activation and Degradation of IκBα

The activity of IκBα is tightly regulated. In response to various cellular signals, a key event is the phosphorylation of IκBα at specific serine residues, notably serine 32 and 36. This phosphorylation event marks IκBα for degradation by the proteasome. This process is often mediated by the IκB kinase (IKK) complex.

Following degradation, the nuclear localization signals of NF-κB are unmasked, allowing the transcription factor to translocate into the nucleus. Once in the nucleus, NF-κB can bind to specific DNA sequences and regulate the expression of a wide array of genes involved in immune responses, inflammation, cell proliferation, and survival.

Research and Applications: Antibodies and Kits

The critical role of IκBα in cellular signaling has led to the development of numerous research tools, including IkB-alpha antibodies. These antibodies are essential for detecting and quantifying IκBα in various experimental settings. Researchers utilize Rabbit Polyclonal IKB alpha antibody preparations, as well as monoclonal antibodies like the NFKBIA/IkB alpha Antibody (H-4), for techniques such as Western blotting (WB), immunohistochemistry (IHC), immunofluorescence (IF), and flow cytometry (FCM). Specific antibodies, such as the Anti-IKB alpha antibody [E130] KO tested, are designed to detect both the phosphorylated and non-phosphorylated form of the serine 32 region of IKB alpha, providing valuable insights into the activation status of the protein.

Furthermore, specialized kits like the IKB-alpha (phospho Tyr305) Cell-Based ELISA Kit allow for the quantitative determination of phosphorylated IκBα in cellular assays, offering a sensitive method to study signaling pathways. The availability of IkB-alpha recombinant proteins, such as Recombinant Human IkB-alpha His Protein, also facilitates biochemical studies and drug discovery efforts.

Clinical Significance and Related Conditions

Dysregulation of the NF-κB pathway, often involving IκBα, has been implicated in a variety of diseases. For instance, mutations in the NFKBIA gene are associated with conditions such as Ectodermal Dysplasia and Immunodeficiency 2. Research has also shown that IκBα is involved in the proliferation of human Burkitt lymphoma Daudi cells, possibly through the MAP kinase pathway, highlighting its broader role in cellular processes beyond just immune responses.

The complex interplay between IκBα and NF-κB underscores the importance of this regulatory axis in maintaining cellular homeostasis and responding to external stimuli. Continued research into IκBα and its interactions will undoubtedly lead to a deeper understanding of numerous biological processes and the development of novel therapeutic strategies for a range of diseases. The field of Immunome Knowledge Base (IKB) also contributes to our understanding of these intricate molecular networks.